Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans

Clinical and Experimental Immunology

Volumn 113, Issue 3, 1998, Pages 401-406

  Louis, E ^a   Franchimont, D ^a   Piron, A ^a   Gevaert, Y ^a   Schaaf Lafontaine, N ^a   Roland, S ^a   Mahieu, P ^a   Malaise, M ^a   De Groote, D ^a   Louis, R ^a   Belaiche, J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

CD14; Gene; Tumour necrosis factor; Whole blood

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL; CELL CULTURE; CYTOKINE PRODUCTION; DNA POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD14; CELLS, CULTURED; FEMALE; GENOTYPE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 7344251714     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00662.x     Document Type: Article

References (40)

1. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1997; 229:869-71.
2. Arditi M, Manogue KR, Caplan M, Yogev R. Cerebrospinal fluid cachetin/tumor necrosis factor-α and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis 1990; 162:139-47.
3. Reinecker HC, Steffen M, Witthoeft T et al. Enhanced secretion of tumour necrosis factor alpha, IL-6 and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94:174-81.
4. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet 1991; 338:732-6.
5. Van Dullemen HM, Van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor monoclonal antibody (cA2). Gastroenterology 1995; 109:129-35.
6. Elliott MJ, Maini RN, Feldmann M et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344:1105-10.
7. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330:662-4.
8. Westendorp RGJ, Langermans JAM, Huizinga TWJ, Elouali AH, Verweij CL, Boomsma DI, Vandenbrouke JP. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349:170-3.
9. Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin gene. J Immunol 1991; 147:1053-9.
10. Wilson AG, de Vreis N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177:557-60.
11. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371:508-11.
12. Roy S, McGuire W, Mascie-Taylor CGN, Saha B, Hazra SK, Hill AVS, Kwiatowski D. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997; 176:530-2.
13. Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OSM, Jennings R, Mibena E, Mabey DCW. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid. Infect Immun 1997; 65:1003-6.
14. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, Blackwell JM. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182:1259-64.
15. Louis E, Satsangi J, Roussomoustakaki M, Parkes M, Fanning G, Welsh K, Jewell D. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996; 39:705-10.
16. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-9.
17. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor-alpha (TNF-alpha) -308 promoter polymorphism in TNF-alpha gene regulation. J Inflam 1996; 46:32-41.
18. De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4:239-48.
19. Entzian P, Linnemann K, Schlaak M, Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996; 153:1080-6.
20. Ziegler-Heitbrock HWL, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993; 14:121-5.
21. Schutt C, Schilling T, Grunwald U, Schonfeld W, Kruger C. Endotoxin-neutralizing capacity of soluble CD14. Res Immunol 1992; 143:71-78.
22. Manogue KR, Van Deventer SJH, Cerami A. Tumor necrosis factor alpha or cachectin. In: Thomson AW, ed. The cytokine handbook. London: Academic Press, 1991:241-56.
23. De Groote D, Gevaert Y, Lopez M et al. Novel method for the measurement of cytokine production by a one-stage procedure. J Immunol Methods 1993; 163:259-67.
24. Verjans GM, Brinkman BMN, van Doornik CEM, Kijlstra A, Verweij CL. Polymorphism of tumor necrosis factor-alpha at position -308 in relation ankylosing spondylitis. Clin Exp Immunol 1994; 97:45-47.
25. Bunce M, Taylor CJ, Welsh KI. Rapid HLA-DQB typing by eight PCR amplifications with sequence-specific primers (PCR-SSP). Hum Immunol 1993; 37:201-6.
26. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: prevalence to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87:1233-7.
27. Pociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23:224-31.
28. + patients define Crohn's disease and ulcerative colitis specific genotypes. Gastroenterology 1994; 106:A754.
29. Goyert SM, Ferrero EM, Seremetis SV, Winchester RJ, Silver J, Mattisson AC. Biochemistry and expression of myelomonocytic antigens. J Immunol 1986; 137:3909-14.
30. 3. Cancer Res 1987; 47:2236-42.
31. Lauener RP, Goyert SM, Geha RS, Vercelli D. Interleukin-4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol 1990; 20:2375-81.
32. Passlick B, Flieger D, Ziegler-Heitbrock HWL. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1984; 74:2527-34.
33. Ziegler-Heitbrock HWL, Ströbel M, Kieper D et al. Differential expression of cytokines in human blood monocyte subpopulations. Blood 1992; 79:503-11.
34. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991; 147:1567-74.
35. Haziot A, Rong GW, Bazil V, Silver J, Goyert SM. Recombinant soluble CD14 inhibits LPS induced tumor necrosis factor-alpha produced by cells in whole blood. J Immunol 1994; 152:5868-76.
36. Martin TR, Mathison JC, Tobias PS, Leturcq DJ, Moriarty AM, Maunder RJ, Ulevitch RJ. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implication for cytokine production in normal and injured lungs. J Clin Invest 1992; 90:2209-19.
37. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164:777-93.
38. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-76.
39. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin-10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
40. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variations and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99:303-10.